Clinical trial
Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
NCT00026780 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026780 |
|---|---|
| Title | Eligibility Screening for a NCI Pediatric Oncology Branch Research Study |
| Official title | Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Ewing Sarcoma, Osteosarcoma, Neuroblastoma, Acute Lymphoblastic Leukemia, Neurofibromatosis Type 1 |
| Enrollment | 1,720 |
| Start date | Sep 24, 2001 |
| Primary completion | Oct 7, 2020 |
| Completion | Oct 7, 2020 |
| First posted | Nov 15, 2001 |
| Last update posted | Oct 8, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: